Terms: = Ovarian cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Treatment
3 results:
1. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.
Bi E; Li R; Bover LC; Li H; Su P; Ma X; Huang C; Wang Q; Liu L; Yang M; Lin Z; Qian J; Fu W; Liu YJ; Yi Q
J Clin Invest; 2018 Nov; 128(11):4821-4831. PubMed ID: 30277474
[TBL] [Abstract] [Full Text] [Related]
2. Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.
Uusi-Kerttula H; Davies J; Coughlan L; Hulin-Curtis S; Jones R; Hanna L; Chester JD; Parker AL
Oncotarget; 2016 May; 7(19):27926-37. PubMed ID: 27056886
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of a20 and other OTU deubiquitinases by reversible oxidation.
Kulathu Y; Garcia FJ; Mevissen TE; Busch M; Arnaudo N; Carroll KS; Barford D; Komander D
Nat Commun; 2013; 4():1569. PubMed ID: 23463012
[TBL] [Abstract] [Full Text] [Related]
